Cytokine analysis to evaluate severity in primary open-angle glaucoma and exfoliative glaucoma.

Area of Science:

• Ophthalmology and immunology research.
• Biomarker discovery for ocular diseases.

Background:

• Glaucoma is a leading cause of irreversible blindness.
• Inflammation is implicated in glaucoma pathogenesis and progression.
• Identifying reliable biomarkers for glaucoma severity is crucial for patient management.

Purpose of the Study:

• To investigate tear and aqueous humor cytokines as potential biomarkers for evaluating glaucoma severity.
• To compare cytokine profiles in patients with exfoliative glaucoma (XFG), primary open-angle glaucoma (POAG), and healthy controls.

Main Methods:

• Cross-sectional study involving 15 XFG patients, 43 POAG patients, and 33 controls.
• Collection of tear and aqueous humor samples.
• Analysis of 27 inflammatory cytokines using the Bio-Plex Pro Human Cytokine 27-Plex Immunoassay.

Main Results:

• Statistically significant differences in specific cytokines (e.g., IL-2, IL-4, IL-9, IL-12, IL-15, FGF-basic) were found in tear samples across study groups.
• Significant differences in other cytokines (e.g., IL-5, IL-6, IL-12, MCP-1) were observed in aqueous humor.
• Elevated levels of interleukin-4 (IL-4) and interleukin-15 (IL-15) correlated with the number of topical medications used, while IL-9 and IL-15 were associated with visual field mean defect, suggesting a link to glaucoma severity.

Conclusions:

• Inflammation plays a significant role in glaucoma.
• Certain cytokines in tear and aqueous humor show potential as biomarkers for assessing glaucoma severity and may be influenced by treatment regimens.